Round table discussion: practical issues in the management of dyslipidaemic patients

[The quality-of-life questionnaire QLS-H: validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population].

Annales d'endocrinologie·2004

[Hormone replacement therapy at menopause in the diabetic woman].

Diabetes & metabolism·2002

PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

The Journal of clinical endocrinology and metabolism·2001

[Role of diet in cardiovascular prevention].

Annales de medecine interne·2001

Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrix.

Pathologie-biologie·2001

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

Atherosclerosis·2026

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study.

Atherosclerosis·2026

Impact of saturated fat absorption on serum low density lipoprotein-cholesterol response to the replacement of saturated with unsaturated fats in healthy males. The 'Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention-2 (RISSCI-2)' non-randomised sequential dietary intervention study.

Atherosclerosis·2026

Mapping the modifiable exposome for ischemic stroke: association, causality, and preventive potential.

Atherosclerosis·2026

Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events.

Atherosclerosis·2026

Effect of in-hospital initiation of alirocumab on clinical outcomes in Chinese ACS patients: findings from the Chinese Cardiovascular Association (CCA) Database-Chest Pain Center.

Atherosclerosis·2026

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

JACC. Heart failure·2026

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

European journal of preventive cardiology·2026

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Polish archives of internal medicine·2026

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026

Related Experiment Videos

Round table discussion: practical issues in the management of dyslipidaemic patients

Related Concept Videos

[The quality-of-life questionnaire QLS-H: validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population].

[Hormone replacement therapy at menopause in the diabetic woman].

PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

[Role of diet in cardiovascular prevention].

Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrix.

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study.

Impact of saturated fat absorption on serum low density lipoprotein-cholesterol response to the replacement of saturated with unsaturated fats in healthy males. The 'Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention-2 (RISSCI-2)' non-randomised sequential dietary intervention study.

Mapping the modifiable exposome for ischemic stroke: association, causality, and preventive potential.

Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events.

Effect of in-hospital initiation of alirocumab on clinical outcomes in Chinese ACS patients: findings from the Chinese Cardiovascular Association (CCA) Database-Chest Pain Center.

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Related Experiment Videos

Round table discussion: practical issues in the management of dyslipidaemic patients

Related Concept Videos

Related Articles